Katten‘s ’patent litigation practice specializes in Hatch-Waxman cases for leading generic drug companies. Recently, the team worked on a high-profile case representing Sun Pharmaceutical Industries in defending their generic version of Ozempic. Deepro Mukerjee, based in New York, is ‘a stand-out patent litigator’ who oversees trial and appellate proceedings. Mukerjee also has experience managing IPR proceedings before the PTAB. Mukerjee chairs the department alongside New-York-based Lance Soderstrom, a seasoned litigator with expertise in pharmaceutical compounds and medical devices, and Chicago-based Brian Sodikoff, who also focuses on Hatch-Waxman patent litigation, drawing on his background in competition law.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Extremely competent group of attorneys, led by Mr Deepro Mukerjee. They use common sense, value-driven billing with an eye towards results.’
- ‘Mr. Deepro Mukerjee is a stand-out patent litigator, immensely talented and results-driven, and leader of the patent litigation team at Katten. He has a keen understanding of his client's business needs and focuses his advice on a legal and business perspective. ’
- ‘The Katten patent litigation team is excellent. Their legal analysis and litigation skills are top-tier. They are very easy to work with and work within our budgets.’
- ‘Deepro Mukerjee, Lance Soderstrom, Joe Janusz, and Jitty Malik are an excellent patent litigation team. They have represented us in multiple Hatch-Waxman cases. They have obtained great results for us while keeping within budget. They are all also incredibly easy to work with.'
Key clients
- Apotex Corp. / Apotex Inc.
- Avocados Plus
- Bel Fuse Inc.
- Biocon Pharma Ltd.
- Bold Limited
- CIPLA Limited
- Fordham University
- Haemonetics Corporation
- Lupin Pharmaceuticals, Inc. / Lupin Limited
- Meitheal Pharmaceuticals
- Micro Labs, Ltd.
- Sawai Pharmaceutical Co., Ltd.
Work highlights
Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Ozempic, a popular diabetes drug that people also take for weight loss.
Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Wegovy, an injectable weight-loss medication for adults with obesity or excess weight with weight-related conditions.
Representing Sun Pharmaceuticals (Sun) in ANDA litigation involving Sun’s attempt to defeat the brand patents for the drug Xtandi, also referred to as enzalutamide, a medication used in the treatment of prostate cancer.
Practice head
Deepro Mukerjee; Lance Soderstrom; Brian Sodikoff
Other key lawyers
Joe Janusz; Jitty Malik